en.Wedoany.com Reported - Saltroad, a clinician-led provider of Speech and Language Therapy (SLT) services, has secured £1.5 million in funding and acquired Ogma, an AI documentation platform designed specifically for SLT. The funding round was led by Techstart Ventures, with participation from Ascension, ScaleX, and a group of prominent angel investors.
It is estimated that one in five children—approximately 2 million in the UK—requires support with speech, language, and communication, yet existing services fall far short of meeting this demand. Service models built for a different era struggle to keep pace, forcing families and therapists to contend with trade-offs: reports replacing therapy, time quotas, endless administrative work, and mismatched caseloads.
Saltroad's premise is that this is not inevitable. The company enables families to privately access National Health Service (NHS) speech and language therapists, offering a broader pool of professionals to choose from, matching therapists to children's clinical needs without waiting lists, and at costs lower than traditional private therapy.
The acquisition of Ogma transforms raw materials from the therapy process into structured, clinically useful notes, reducing after-hours administrative work and standardizing documentation quality across the entire team. By embedding AI tools within its network of over 1,000 therapists across the UK, Saltroad aims to increase the number of children each therapist can treat without compromising clinical quality or therapist well-being.
Darren Lester, co-founder and CEO of Saltroad, stated that too many children wait months or even years for help during their most critical years. "It's not that therapists aren't working hard enough—it's a system that was never built for the scale or diversity of demand we see today. Saltroad exists to put therapy back into speech and language therapy and reach families that the current system cannot serve. This funding, along with the acquisition of Ogma, will support how we build this system and deliver tailored 1:1 speech therapy at scale."
Audrey Osborne, Partner at Techstart Ventures, said: "We have supported Saltroad from the start, and everything since has deepened our belief in Darren, Debi, and their team. A scalable therapist team combined with purpose-built AI is exactly the kind of ambition we want to back in Northern Ireland." Toyosi Ogedengbe, Partner at Ascension, added: "We look for teams solving truly important problems at scale, and Saltroad fits that bill. From the outset, Saltroad has clearly seen a real and growing problem. Combining AI with skilled clinicians, rather than replacing them, is the right way to expand accessibility without lowering standards."
This funding and acquisition support Saltroad's plan to build an AI-enabled SLT workforce, combining the flexibility of a partnership model with dedicated tools that allow therapists to spend more time with children who need support and less on administrative tasks.
